The smallest active 10-amino-acid fragment of the kisspeptin hormone family.
PRODUCT PROFILE
Kisspeptin-10
£54.00
Kisspeptin-10 is a short part of the natural kisspeptin hormone. Researchers use it to study the hormone chain that controls reproductive function. It can create a relatively quick, brief signal compared with the longer Kisspeptin-54 form.
Kisspeptin-10 acts for a shorter time than Kisspeptin-54, making the length of the research signal the clearest difference.
- Evidence stageHuman clinical research
- AvailabilityAvailable · 10 in stock
- Batch recordPublished after verification
- DispatchConfirmed at checkout
10 in stock
PRODUCT INFORMATION
Clear first. Detailed when needed.
What this material is+
Kisspeptin-10 is a short part of the natural kisspeptin hormone. Researchers use it to study the hormone chain that controls reproductive function. It can create a relatively quick, brief signal compared with the longer Kisspeptin-54 form.
Research focus+
Researchers study how Kisspeptin-10 activates reproductive hormone signalling, including the release of hormones that help control ovulation and testosterone production.
How the mechanism differs+
It activates the KISS1 receptor, which signals the brain to start the reproductive-hormone chain.
Evidence and limitations+
Human endocrine challenge studies exist, but therapeutic use remains investigational and context-specific.
Testing and batch documentation+
No live certificate is shown for this staging item. ADINA will only publish a batch document after the product identifier, test method and result have been checked.
RESEARCH PROFILE
Understand the distinction.
Researchers study how Kisspeptin-10 activates reproductive hormone signalling, including the release of hormones that help control ovulation and testosterone production.
It activates the KISS1 receptor, which signals the brain to start the reproductive-hormone chain.
Kisspeptin-10 acts for a shorter time than Kisspeptin-54, making the length of the research signal the clearest difference.
Human endocrine challenge studies exist, but therapeutic use remains investigational and context-specific.
Educational research context only. This information is not dosage, administration or personal-use guidance.




